Literature DB >> 15245737

Immunological memory to viral infection.

Mark K Slifka1.   

Abstract

Immunological memory is defined by the ability of a host to remember a past encounter with a specific pathogen and to respond to it in an effective manner upon re-exposure. How long immunological memory can be maintained in the absence of re-infection continues to be a subject of great controversy. Recent studies on immunity following smallpox vaccination demonstrate that T-cell memory declines steadily with a half-life of 8-15 years, whereas antiviral antibody responses are maintained for up to 75 years without appreciable decline. By combining recent advances in quantitative immunology with historical accounts of protection against smallpox dating back to the time of Edward Jenner, we are gaining a better understanding of the duration and magnitude of immunological memory and how it relates to protective immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245737     DOI: 10.1016/j.coi.2004.05.013

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  18 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Quantitation of rare memory B cell populations by two independent and complementary approaches.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  J Immunol Methods       Date:  2006-10-04       Impact factor: 2.303

3.  Protective immunity following vaccination: how is it defined?

Authors:  Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Hum Vaccin       Date:  2008-02-19

Review 4.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus.

Authors:  Eric J Yager; In-Jeong Kim; Michael L Freeman; Kathleen G Lanzer; Claire E Burkum; Tres Cookenham; David L Woodland; Marcia A Blackman
Journal:  Immun Ageing       Date:  2010-02-02       Impact factor: 6.400

Review 6.  Neonatal Vaccination: Challenges and Intervention Strategies.

Authors:  Matthew C Morris; Naveen Surendran
Journal:  Neonatology       Date:  2016-01-13       Impact factor: 4.035

7.  Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.

Authors:  Bénédicte Puissant-Lubrano; Philippe Bossi; Frederick Gay; Jean-Marc Crance; Olivia Bonduelle; Daniel Garin; François Bricaire; Brigitte Autran; Behazine Combadière
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

8.  Long-lived plasma cells in human bone marrow can be either CD19+ or CD19.

Authors:  Siggeir F Brynjolfsson; Maziar Mohaddes; Johan Kärrholm; Mary-Jo Wick
Journal:  Blood Adv       Date:  2017-05-19

9.  Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Authors:  D Huw Davies; Megan M McCausland; Conrad Valdez; Devan Huynh; Jenny E Hernandez; Yunxiang Mu; Siddiqua Hirst; Luis Villarreal; Philip L Felgner; Shane Crotty
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.

Authors:  Erika Hammarlund; Anindya Dasgupta; Clemencia Pinilla; Patricia Norori; Klaus Früh; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.